Dolby Laboratories (DLB) has drawn investor attention after a period where the share price shows mixed returns, with gains over the past month and past 3 months, but weaker performance over the past year.
See our latest analysis for Dolby Laboratories.
At a share price of US$66.02, Dolby’s short term momentum has softened, with a 7 day share price return of a 3.18% decline, while the 1 year total shareholder return of a 20.32% decline points to sentiment that has cooled over a longer stretch.
If this mixed picture has you looking beyond a single name, it could be a good time to broaden your search and check out 23 top founder-led companies as potential new ideas.
With Dolby reporting US$1.34b in revenue and US$240.52m in net income, plus the current share price sitting at US$66.02, the real question is whether today’s valuation leaves upside on the table or if the market is already pricing in future growth.
Most Popular Narrative: 27% Undervalued
With Dolby’s fair value narrative sitting at $90.50 against a last close of $66.02, the gap between price and expectations is hard to ignore.
Strategic expansion into direct to consumer apps and services (e.g., Dolby.io, cloud based audio tools) provides new, higher margin recurring revenue streams that diversify away from cyclical hardware markets, supporting improved earnings quality and margin uplift over time.
Curious what has to happen for that higher earnings quality to fully show up in the numbers? Revenue, margins and future earnings are all wired into this story. The full narrative explains how those moving parts connect to today’s $90.50 fair value estimate.
Result: Fair Value of $90.50 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, you still need to watch for revenue pressure if device makers lean into cheaper or royalty free codecs, as well as any prolonged softness in core consumer electronics demand.
Find out about the key risks to this Dolby Laboratories narrative.
Next Steps
If this mix of potential and concern has you on the fence, it is worth acting soon to review the data yourself and stress test your thinking, then check out 4 key rewards and 1 important warning sign to see how the key risks and rewards stack up side by side.
Ready for more investment ideas?
If you stop with just one company, you risk missing other opportunities that better fit your style, so use the Simply Wall St Screener to widen your field.
- Target potential mispricings by scanning our list of 55 high quality undervalued stocks that pair quality fundamentals with prices that may not fully reflect them yet.
- Strengthen your income plan by reviewing 13 dividend fortresses, focusing on companies offering solid yields with the potential to support ongoing payouts.
- Sleep easier by checking 81 resilient stocks with low risk scores, a set of companies with lower risk scores that could help balance out the bumpier parts of your portfolio.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com